HeartBeam has been approved by the FDA for its home device that detects heart attacks.

Oct 5, 2026, 1:54 PM ETTrialRead the original at Benzinga

Good for BEAT

HeartBeam received a special FDA designation that gives its device faster regulator review and closer regulator contact. The company still needs a larger study and clearance for the planned heart-attack use, but the FDA step supports progress.

BEAT · HeartBeam, Inc.

AI read · Good for BEAT

The AI's read

This gives HeartBeam quicker access to regulators and a faster review path as it works toward a possible heart-attack use. Recent study findings also supported the decision. The work is not finished. HeartBeam still plans a larger study, patient enrollment, and a later request to expand the device’s use. It has not received clearance for that use.

Get alerts for BEAT

Follow HeartBeam, Inc. (BEAT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BEAT

Free on the App Store and Google Play, or on the web.